JOURNAL ARTICLE

Factors Predicting Failure of Medical Treatment for Fibroadenosis.

  • Published In: Zagazig University Medical Journal, 2025, v. 31, n. 12. P. 5980 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Tantawy, Ahmed Magdy Ibraheem; Omar, Mansour Mohamed Morsy; Ali, Ramadan Mahmoud Mohamed; Israel, Joseph Rizk 3 of 3

Abstract

Background: Fibroadenosis, also known as fibrocystic breast disease, is a common benign breast condition affecting women of reproductive age. While medical treatment--often involving hormonal modulation, analgesics, and lifestyle modifications--can alleviate symptoms, a subset of patients fail to achieve adequate relief, leading to persistent symptoms or recurrence. Identifying factors that predict failure of medical therapy is critical for optimizing management strategies, reducing unnecessary treatment delays, and guiding early surgical intervention when indicated. So, we aimed to determine the factors predicting failure of medical treatment for fibroadenosis Methods: This cross-sectional study was conducted in the General Surgery Department of Zagazig University Hospital, Zagazig on patients who were presented with breast pain primarily attributed to fibroadenosis at the General Surgery Department of Zagazig University Hospital during the study period. Results: Regarding univariate Associations, older age, diabetes, hypertension, positive family history, infertility, cyclical tenderness, breast heaviness, and palpable lumps were significantly linked to treatment failure (p < 0.05). Regarding multivariate Analysis, history of infertility (OR ≈ 43, p = 0.019) and cyclical breast tenderness (OR ≈ 43, p = 0.019) emerged as independent predictors of medical management failure. Other variables lost significance after adjustment. Conclusion: Most fibroadenosis patients responded positively to a regimen of evening primrose oil, NSAIDs, and cabergoline, while infertility history and cyclical breast tenderness were identified as significant independent predictors of treatment failure. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Zagazig University Medical Journal. 2025/12, Vol. 31, Issue 12, p5980
  • Document Type:Article
  • Subject Area:Consumer Health
  • Publication Date:2025
  • ISSN:1110-1431
  • DOI:10.21608/zumj.2025.417278.4131
  • Accession Number:190881275
  • Copyright Statement:Copyright of Zagazig University Medical Journal is the property of Association of Arab Universities and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.